| CAS NO: | 198904-31-3 |
| 包装 | 价格(元) |
| 100mg | 电议 |
| 250mg | 电议 |
| 500mg | 电议 |
| 生物活性 | Atazanavir (BMS-232632), a highly selectiveHIV-1proteaseinhibitor, is the first protease inhibitor approved for once-daily administration[1]. Atazanavir (BMS-232632) is a substrate and inhibitor ofCYP3A4, and an inhibitor and inducer ofP-glycoprotein(P-gp)[2]. Atazanavir is also aSARS-CoV3CLproinhibitor with anIC50of 3.49 μM[3]. | ||
| IC50& Target |
| ||
| Clinical Trial | |||
| 分子量 | 704.86 | ||
| Formula | C38H52N6O7 | ||
| CAS 号 | 198904-31-3 | ||
| 中文名称 | 阿扎那韦 | ||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com